1 citations,
January 2021 in “Indian Dermatology Online Journal” The document reviewed the use of platelet-rich plasma (PRP) in treating androgenetic alopecia (AGA), highlighting its potential to stimulate hair growth through various pathways. Despite promising results, the effectiveness of PRP was limited by inconsistent preparation methods and lack of standardization. Meta-analyses of randomized controlled trials (RCTs) showed an increase in hair diameter and count, but results were not statistically significant due to high methodological variability. The manual double-spin method was recommended for PRP preparation, with a platelet concentration of 1 to 1.5 million/μL being optimal. PRP showed better hair growth results compared to finasteride, minoxidil, and low-level laser therapy, and was effective in women unresponsive to minoxidil. The study concluded that PRP should be part of a multipronged approach for treating AGA due to its minimal adverse effects and significant efficacy.
January 2021 in “Türk plastik cerrahi dergisi” The study evaluated the efficacy and safety of activated platelet-rich plasma (aPRP) in treating androgenetic alopecia (AGA) in 40 male patients, with 35 completing the study. Patients received 5 sessions of aPRP injections, spaced 15 days apart, with aPRP injected into one half of the scalp and placebo in the other half. Results at 1 and 3 months follow-up showed a significant increase in hair count, hair density, and anagen/telogen ratio in the aPRP-treated areas compared to placebo. The study concluded that aPRP is a safe and effective treatment for AGA, with a stabilizing effect on hair fall and potential to prevent progression of alopecia in its early stages. No major side effects were reported, but further studies with larger cohorts and longer follow-up periods were recommended.
37 citations,
January 2017 in “Anais Brasileiros De Dermatologia” AGA more common in men, increases with age, linked to family history, hypertension, dyslipidemia, and smoking.
30 citations,
January 2000 in “Dermatologic Clinics” Finasteride and minoxidil are effective FDA-approved treatments for androgenetic alopecia.
15 citations,
February 2013 in “International Urology and Nephrology” Low-dose finasteride may cause fertility issues, but stopping it can improve sperm quality and lead to pregnancy.
18 citations,
May 2013 in “Annals of Dermatology” AGA increased yearly, type I most common, and family history and seborrheic dermatitis often linked.
1 citations,
May 2015 in “Journal of The American Academy of Dermatology” Oral clindamycin and rifampicin are the most effective treatments for Folliculitis decalvans.
20 citations,
January 2012 in “International journal of trichology” Steroids are the best treatment for Alopecia Areata with few side effects.
17 citations,
September 2017 in “Journal of Cosmetic Dermatology” Women with PCOS in North China often have hirsutism and acne, with hirsutism linked to metabolic issues.
37 citations,
October 2015 in “European Journal of Human Genetics” Genetic data can predict male-pattern baldness with moderate accuracy, especially for early-onset cases in some European men.
May 2024 in “International journal of research in dermatology” Low vitamin D levels are linked to increased risk of male pattern baldness.
192 citations,
February 2015 in “Journal of the American Academy of Dermatology” Targeted cancer therapies often cause serious skin problems that need careful management.
55 citations,
October 2019 in “Dermatology and therapy” Drugs targeting the JAK/STAT pathway can improve atopic dermatitis but vary in effectiveness for vitiligo and alopecia areata, with generally mild safety concerns.
49 citations,
August 2004 in “Anesthesiology” The document concludes that more research is needed to understand how to treat muscle pain with drugs.
12 citations,
January 2015 in “Indian Journal of Dermatology, Venereology and Leprology” Negative expectations can cause adverse effects in dermatology treatments, like with finasteride for baldness, and careful communication can help reduce these nocebo responses.
6 citations,
March 2019 in “Photodiagnosis and Photodynamic Therapy” A wearable cap-like device using light therapy reduced scalp skin lesions by 71% and was painless.
1 citations,
May 2013 in “Journal of the Egyptian Women's Dermatologic Society (Print)” PSA could be a marker for hyperandrogenism in women, but more research is needed.
May 2024 in “Journal of Education, Health and Sport” Current treatments for folliculitis decalvans include antibiotics, isotretinoin, and potential new therapies like botulinum toxin A and PRP.
9 citations,
March 2018 in “Indian Journal of Endocrinology and Metabolism” May 2023 in “Dermatologic Therapy” A new hand-held light therapy device was found to be safe and effective for treating mild-to-moderate acne.
January 2023 in “The Egyptian Journal of Hospital Medicine” January 2022 in “Journal of Cosmetics, Dermatological Sciences and Applications” 23 citations,
September 2019 in “Dermatology practical & conceptual” The study concluded that AAI and DAA are forms of the same disease, with different symptoms in men and women, and that corticosteroid treatment is effective.
1 citations,
August 2002 in “PubMed” 6 citations,
September 2019 in “Indian Journal of Dermatology” 13 citations,
August 1991 in “The Journal of the American Osteopathic Association” 12 citations,
May 2019 in “International Journal of Trichology” 11 citations,
January 2019 in “International Journal of Trichology” 3 citations,
November 2019 in “International Journal of Trichology” December 2021 in “International Journal of Trichology”